As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy. In a video interview with ...

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

A recent Pharmaceutical Executive article highlights how antibody-drug conjugates are experiencing a renaissance in oncology, with innovations in targeting, linker technology, and payload design ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

In an interview with Pharmaceutical Executive, Barry Quart, CEO, Connect Biopharma, discussed his decision to join the company to advance rademikibart—a novel biologic therapy showing promise in ...

The impact of Alzheimer’s disease is a prominent one, as it impacts an estimated 6.9 million US residents ages 65 and older. 1 This makes it the most common form of dementia, while other forms include ...